Royal Fund Management’s AbbVie ABBV Stock Holding History

Royal Fund Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-600	Closed	-$1.15K	–	293
2026 Q1	$1.15K	Buy	600 +596	+14,900%	+$132K	﹤0.01%	294
2025 Q4	$760	Sell	4 -4	-50%	-$911	﹤0.01%	281
2025 Q3	$3.66K	Sell	8 -792	-99%	-$161K	﹤0.01%	254
2025 Q2	$148K	Sell	800 -200	-20%	-$37.2K	0.01%	288
2025 Q1	$204K	Buy	+1,000	New	+$194K	0.02%	278
2024 Q4	–	Sell	-2,200	Closed	-$434K	–	287
2024 Q3	$434K	Buy	+2,200	New	+$411K	0.03%	260
2024 Q2	–	Sell	-2,400	Closed	-$437K	–	281
2024 Q1	$437K	Sell	2,400 -500	-17%	-$86.2K	0.04%	246
2023 Q4	$449K	Buy	+2,900	New	+$423K	0.05%	224
2023 Q3	–	Sell	-3,300	Closed	-$445K	–	266
2023 Q2	$445K	Sell	3,300 -200	-6%	-$29.3K	0.06%	211
2023 Q1	$558K	Sell	3,500 -700	-17%	-$107K	0.08%	201
2022 Q4	$679K	Buy	+4,200	New	+$644K	0.11%	157
2022 Q2	–	Sell	-3,900	Closed	-$632K	–	199
2022 Q1	$632K	Buy	+3,900	New	+$567K	0.09%	133

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Royal Fund Management's ABBV Position: Q2 2026 in Review

Royal Fund Management increased its AbbVie (ABBV) stake by 7.6% in Q2 2026, buying an estimated $772K and bringing the position to 50,828 shares worth $12.8M. The position accounts for 1.07% of the portfolio, ranked #20.

Royal Fund Management first reported a position in ABBV in Q4 2016 and has held it in 39 quarters since. The position peaked at $15.4M in Q4 2017. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Royal Fund Management held 50,828 shares of AbbVie worth $12.8M as of Q2 2026.
Royal Fund Management bought 3,590 AbbVie shares in Q2 2026, an estimated $772K.
AbbVie made up 1.07% of Royal Fund Management's portfolio in Q2 2026, its #20 holding.
Royal Fund Management first reported a position in AbbVie in Q4 2016 and has held it in 39 quarters since.
Royal Fund Management's AbbVie position peaked at $15.4M in Q4 2017.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Royal Fund Management's 13F filing for Q2 2026, filed 20 Jul 2026.